medicineのメーカーや取扱い企業、製品情報、参考価格、ランキングをまとめています。
イプロスは、 製造業 ・ BtoB における情報を集めた国内最大級の技術データベースサイトです。

medicine - メーカー・企業35社の製品一覧とランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

medicineのメーカー・企業ランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
  4. 4 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology
  5. 5 KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
企業ランキングへ

medicineの製品ランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. Pharmaceutical CDMO services 大塚化学
  2. Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  3. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  4. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  5. 4 For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept

medicineの製品一覧

196～210 件を表示 ／ 全 599 件

表示件数
[Research Material] Global Market for Ischemic Stroke Treatment Drugs

[Research Material] Global Market for Ischemic Stroke Treatment Drugs

Global Market for Ischemic Stroke Treatment Drugs: Tissue Plasminogen Activator, Anticoagulants, Antiplatelet Agents, Antihypertensives, Others, Hospitals, Clinics, Outpatient ...

This research report (Global Ischemic Stroke Drugs Market) investigates and analyzes the current state and outlook for the global market of ischemic stroke treatment drugs over the next five years. It includes information on the overview of the global ischemic stroke treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include tissue plasminogen activators, anticoagulants, antiplatelet agents, antihypertensives, and others, while the segments by application focus on hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ischemic stroke treatment drugs. The report also includes the market share of major companies in the ischemic stroke treatment drugs sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Cachexia Treatment

[Research Material] The Global Market for Cachexia Treatment

World Market for Cachexia Treatment: Weight Stabilizers, Appetite Stimulants, Progestogens, Corticosteroids, Combination Therapy, Others, Hospital Pharmacies, Retail Pharmacies, ...

This research report (Global Cachexia Treatment Market) investigates and analyzes the current state and future outlook of the global cachexia treatment market over the next five years. It includes information on the overview of the global cachexia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cachexia treatment market include weight stabilizers, appetite stimulants, progestogens, corticosteroids, combination therapies, and others, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cachexia treatment. It also includes the market share of major companies in cachexia treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Tumor Treatment Drugs

[Research Material] Global Market for Tumor Treatment Drugs

Global Market for Tumor Treatment Drugs: Chemotherapy, Targeted Therapy, Immunotherapy (Biological Therapy), Hormonal Therapy, Others, Hematological Cancers, Breast Cancer, Gastrointestinal Cancers, ...

This research report (Global Oncology Drugs Market) investigates and analyzes the current status and outlook for the global market of oncology drugs over the next five years. It includes information on the overview of the global oncology drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oncology drugs market include chemotherapy, targeted therapy, immunotherapy (biological therapy), hormone therapy, and others, while the segments by application cover hematologic cancers, breast cancer, gastrointestinal cancers, prostate cancer, respiratory cancers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of oncology drugs. It also includes the market share of major companies in oncology drugs, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

[Research Material] Global Market for Non-Hodgkin Lymphoma Treatment Drugs

World Market for Non-Hodgkin Lymphoma Treatment Drugs: Chemotherapy, Targeted Therapy, Clinical Research, Treatment

This research report (Global Non-Hodgkin Lymphoma Therapeutics Market) investigates and analyzes the current status and outlook for the global market of non-Hodgkin lymphoma therapeutics over the next five years. It includes information on the overview of the global non-Hodgkin lymphoma therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on chemotherapy and targeted therapy, while the segments by application target clinical research and treatment. The regional segments calculate the market size of non-Hodgkin lymphoma therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in non-Hodgkin lymphoma therapeutics, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

[Research Material] Global Market for Treatment Drugs for Dilated Cardiomyopathy

Global Market for Treatment of Dilated Cardiomyopathy: Aldosterone Antagonists, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor ...

This research report (Global Dilated Cardiomyopathy Therapeutic Market) investigates and analyzes the current state and future outlook of the global market for dilated cardiomyopathy therapeutics over the next five years. It includes information on the overview of the global dilated cardiomyopathy therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include aldosterone antagonists, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and beta-blockers, while the segments by application focus on hospitals and academic institutions. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dilated cardiomyopathy therapeutics. The report also includes the market share of major companies in the dilated cardiomyopathy therapeutics market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Ebola Treatment

[Research Material] The Global Market for Ebola Treatment

Global Market for Ebola Treatment: Vaccines (in trials), Drugs (in trials), Hospitals, Outpatient Surgery Centers, Specialized Clinics, Army Camps (Veteran Facilities)

This research report (Global Ebola Treatment Market) investigates and analyzes the current state and outlook for the global Ebola treatment market over the next five years. It includes information on the overview of the global Ebola treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Ebola treatment market focus on vaccines (in trials) and drugs (in trials), while the segments by application target hospitals, outpatient surgery centers, specialty clinics, and military camps (veteran facilities). The regional segments calculate the market size for Ebola treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Ebola treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Myocardial Infarction Treatment Drugs

[Research Material] Global Market for Myocardial Infarction Treatment Drugs

Global Market for Myocardial Infarction Treatment Drugs: JVS-200, KR-33028, AMRS-001, ANG-4011, Balixafortide, CA ...

This research report (Global Myocardial Infarction Drug Market) investigates and analyzes the current state and outlook for the global market for myocardial infarction treatment drugs over the next five years. It includes information on the overview of the global myocardial infarction treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include JVS-200, KR-33028, AMRS-001, ANG-4011, Valiciclovir, CAP-1002, Sendelicitide, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myocardial infarction treatment drugs. It also includes the market share of major companies in the myocardial infarction treatment drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Mucopolysaccharidosis Treatments

[Research Material] Global Market for Mucopolysaccharidosis Treatments

World Market for Mucopolysaccharidosis Treatments: Intravenous Injection, Intracerebroventricular (ICV), Hospitals, Clinics, Others

This research report (Global Mucopolysaccharidosis Therapeutics Market) investigates and analyzes the current status and outlook for the global market for mucopolysaccharidosis therapeutics over the next five years. It includes information on the overview of the global mucopolysaccharidosis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on intravenous injection and intracerebroventricular (ICV) administration, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for mucopolysaccharidosis therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in mucopolysaccharidosis therapeutics, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Troprostenil Therapeutics

[Research Material] Global Market for Troprostenil Therapeutics

World Market for Treprostinil Therapeutics: Remodulin, Tyvaso, Orenitram, Hospitals, Clinics

This research report (Global Treprostinil Drugs Market) investigates and analyzes the current state and outlook for the global market of treprostinil therapeutic drugs over the next five years. It includes information on the overview of the global treprostinil therapeutic drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Remodulin, Tyvaso, and Orenitram, while the segments by application focus on hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of treprostinil therapeutic drugs. It also includes the market share of major companies in the treprostinil therapeutic drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

[Research Material] Global Market for Acute Respiratory Distress Syndrome Treatments

Global Market for Acute Respiratory Distress Syndrome Treatments: Methylprednisolone, Hydrocortisone, Injectable Bovine Lung Surfactant, Others, Hospitalized Patients ...

This research report (Global Acute Respiratory Distress Syndrome Therapeutics Market) investigates and analyzes the current state and outlook for the global market for acute respiratory distress syndrome therapeutics over the next five years. It includes information on the overview of the global acute respiratory distress syndrome therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the acute respiratory distress syndrome therapeutics market include methylprednisolone, hydrocortisone, injectable bovine lung surfactant, and others, while the segments by application focus on inpatients and outpatients. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute respiratory distress syndrome therapeutics. It also includes the market share of major companies in the acute respiratory distress syndrome therapeutics market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Smoking Cessation Medications

[Research Material] Global Market for Smoking Cessation Medications

Global Market for Smoking Cessation Medications: NRT Products, Nicotine-Free Products, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Smoking Cessation Drugs Market) investigates and analyzes the current state of the global market for smoking cessation drugs and its outlook for the next five years. It includes information on the overview of the global smoking cessation drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the smoking cessation drug market focus on NRT products and nicotine-free products, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for smoking cessation drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the smoking cessation drug market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Treatment of Factor VIII Deficiency

[Research Material] The Global Market for Treatment of Factor VIII Deficiency

World Market for Treatment of Factor VIII Deficiency: Hemophilia A Drugs, Hemophilia A Inhibitor Treatment, von Willebrand Disease Treatment, Hospitals, Clinics, Others

This research report (Global Factor VIII Deficiency Treatment Market) investigates and analyzes the current status and outlook for the global market for Factor VIII deficiency treatment over the next five years. It includes information on the overview of the global Factor VIII deficiency treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Factor VIII deficiency treatment market focus on hemophilia A drugs, hemophilia A inhibitor treatments, and von Willebrand disease treatments, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for Factor VIII deficiency treatment. It also includes the market share of major companies in Factor VIII deficiency treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Smooth Muscle Sarcoma Treatment Drugs

[Research Material] Global Market for Smooth Muscle Sarcoma Treatment Drugs

World Market for Smooth Muscle Tumor Treatment Drugs: AL-3818, BGB-290, C-21, Others, Clinics, Hospitals, Others

This research report (Global Leiomyosarcoma Drug Market) investigates and analyzes the current state and outlook for the global market of smooth muscle sarcoma treatment drugs over the next five years. It includes information on the overview of the global smooth muscle sarcoma treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AL-3818, BGB-290, C-21, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of smooth muscle sarcoma treatment drugs. It also includes the market share of major companies in the smooth muscle sarcoma treatment drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Chronic Bronchitis Treatment

[Research Material] The Global Market for Chronic Bronchitis Treatment

Global Market for Chronic Bronchitis Treatment: Antibiotics, Anti-inflammatory Drugs, Bronchodilators, Mucolytics, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Chronic Bronchitis Treatment Market) investigates and analyzes the current state and outlook for the global chronic bronchitis treatment market over the next five years. It includes information on the overview of the global chronic bronchitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the chronic bronchitis treatment market focus on antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for chronic bronchitis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in chronic bronchitis treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for the Treatment of Diabetic Peripheral Neuropathy

[Research Material] Global Market for the Treatment of Diabetic Peripheral Neuropathy

Global Market for Treatment of Diabetic Peripheral Neuropathy: Antimunocell, ASP-8477, BNV-222, Capsaicin, CBX-129801 ...

This research report (Global Diabetic Peripheral Neuropathy Treatment Market) investigates and analyzes the current status and outlook for the global market for diabetic peripheral neuropathy treatment over the next five years. It includes information on the overview of the global diabetic peripheral neuropathy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the diabetic peripheral neuropathy treatment market include Antimunocell, ASP-8477, BNV-222, Capsaicin, CBX-129801, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for diabetic peripheral neuropathy treatment. It also includes the market share of major companies in diabetic peripheral neuropathy treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録

medicineに関連する検索キーワード

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.